Top Stories
-
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
-
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Topic
-
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
-
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
Topic
Latest News
- May 21, 2021
Columbia cancer researchers are testing a new chemotherapy regimen for patients with an invasive form of bladder cancer who have limited options beyond radical surgery if initial treatment fails.
Topic
- May 20, 2021
Newly identified immune cells infiltrate tumors in patients with localized kidney cancer and may be driving the cancer’s recurrence, Columbia researchers have found.
- May 18, 2021
Christine Iok In Chio and Xuebing Wu have received 2021 Pershing Square Sohn Prizes for their out-of-the box approaches to cancer research.
- May 10, 2021
Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
- April 2, 2021
In a new study, Columbia cancer researchers have identified a potential new drug target in lung metastases of esophageal squamous cell carcinoma.
- March 24, 2021
Columbia cancer researchers are working to increase the representation of people of color in cancer clinical trials and decrease the health equity gap, with the help of Stand Up to Cancer.
- March 11, 2021
Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients.
- March 1, 2021
Using a new technique that uncovers the hidden tricks cancer cells use to resist immunotherapy, Columbia and MIT researchers have discovered why some melanoma patients do not respond to the therapy.
- February 24, 2021
By deploying CRISPR to make the smallest mutations, researchers are learning how subtle changes to genes contribute to disease.
Topic
- February 18, 2021
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Topic
